Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up.
Control del embarazo en pacientes con lupus eritematoso sistémico/síndrome antifosfolípido. parte 2: seguimiento del embarazo.
Anticoncepción
Antiphospholipid syndrome
Contraception
Embarazo
Lactancia
Lactation
Lupus eritematoso sistémico
Pregnancy
Puerperio
Puerperium
Systemic lupus erythematosus
Síndrome antifosfolípido
Journal
Reumatologia clinica
ISSN: 2173-5743
Titre abrégé: Reumatol Clin (Engl Ed)
Pays: Spain
ID NLM: 101717526
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
19
05
2019
revised:
23
07
2019
accepted:
23
09
2019
pubmed:
30
11
2019
medline:
30
11
2019
entrez:
30
11
2019
Statut:
ppublish
Résumé
In order to agree on the fundamental aspects related to the management of pregnancy in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), the Spanish Societies of Gynaecology and Obstetrics, Internal Medicine and Rheumatology set up a working group for the preparation of three consensus documents. Each of the Scientific Societies involved proposed five representatives based on their experience in the field of pregnancy control in patients with autoimmune diseases. The recommendations were developed following the Delphi methodology. This second document contains the recommendations regarding the management of pregnancy in women with SLE and APS, including complications such as lupus activity, congenital heart block, thrombotic and obstetric manifestations of APS and placental vascular disease. These multidisciplinary recommendations are considered decision-making tools for clinicians involved in the care of patients with SLE/APS during pregnancy.
Identifiants
pubmed: 31780250
pii: S1699-258X(19)30131-7
doi: 10.1016/j.reuma.2019.09.003
pii:
doi:
Types de publication
Journal Article
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
125-131Informations de copyright
Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.